))
Hamilton Morris - The Secret Agenda To Block Psychedelic Therapy
Manage episode 457151314 series 3621753
Content provided by Adam Strauss. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Adam Strauss or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
In this eye-opening premiere of Obsessed with Adam Strauss, Adam sits down with Hamilton Morris—scientist, journalist, and creator of Hamilton’s Pharmacopeia—to uncover the shocking truth behind the FDA’s rejection of a groundbreaking psychedelic therapy. While many believe the decision stemmed from a lack of safety research, Hamilton reveals a far more sinister story: a covert effort by a small group to block this therapy’s approval through underhanded tactics and blatant dishonesty.
Together, Adam and Hamilton unravel the conspiracy that’s putting lives and transformative science at risk. From the work of MAPS (Multidisciplinary Association for Psychedelic Studies) to the political and personal motives driving opposition to psychedelic therapy, this conversation explores how hidden agendas can shape public health policy and block life-changing treatments.
If you think the story of psychedelic therapy is just about science and safety, think again. This episode digs deep into the power struggles, misinformation, and obsession behind one of the most controversial moments in this burgeoning movement.
Topics Covered:
The misconceptions surrounding the FDA’s rejection of psychedelic therapy.
The covert efforts to block this therapy and their far-reaching implications.
The role of capitalism, politics, and misinformation in the approval process.
Why psychedelic therapy could revolutionize mental health treatment.
Key Organizations discussed:
MAPS - A nonprofit organization that developed the psychedelic therapy discussed in this episode and has led clinical trials to bring it to FDA approval. They previously sponsored Adam’s show The Mushroom Cure.
Lykos Therapeutics - The for-profit pharmaceutical arm of MAPS.
Compass Pathways - A for-profit company exploring psilocybin therapy, raising questions about the role of corporate interests in psychedelics. Hamilton used to consult for them.
Psymposia - A media outlet that critically examines the psychedelic industry, including the ethical and political issues surrounding its development.
Join the Obsession:
If you enjoyed this episode, don’t forget to subscribe to Obsessed with Adam Strauss. Share this episode with friends, leave a review, and follow Adam on social media.
Instagram: @atomstrauss
YouTube: AdamStrauss
TikTok: @atomstrauss
Twitter: @atomstrauss
And check out Adam's show The Mushroom Cure here.
…
continue reading
Together, Adam and Hamilton unravel the conspiracy that’s putting lives and transformative science at risk. From the work of MAPS (Multidisciplinary Association for Psychedelic Studies) to the political and personal motives driving opposition to psychedelic therapy, this conversation explores how hidden agendas can shape public health policy and block life-changing treatments.
If you think the story of psychedelic therapy is just about science and safety, think again. This episode digs deep into the power struggles, misinformation, and obsession behind one of the most controversial moments in this burgeoning movement.
Topics Covered:
The misconceptions surrounding the FDA’s rejection of psychedelic therapy.
The covert efforts to block this therapy and their far-reaching implications.
The role of capitalism, politics, and misinformation in the approval process.
Why psychedelic therapy could revolutionize mental health treatment.
Key Organizations discussed:
MAPS - A nonprofit organization that developed the psychedelic therapy discussed in this episode and has led clinical trials to bring it to FDA approval. They previously sponsored Adam’s show The Mushroom Cure.
Lykos Therapeutics - The for-profit pharmaceutical arm of MAPS.
Compass Pathways - A for-profit company exploring psilocybin therapy, raising questions about the role of corporate interests in psychedelics. Hamilton used to consult for them.
Psymposia - A media outlet that critically examines the psychedelic industry, including the ethical and political issues surrounding its development.
Join the Obsession:
If you enjoyed this episode, don’t forget to subscribe to Obsessed with Adam Strauss. Share this episode with friends, leave a review, and follow Adam on social media.
Instagram: @atomstrauss
YouTube: AdamStrauss
TikTok: @atomstrauss
Twitter: @atomstrauss
And check out Adam's show The Mushroom Cure here.
2 episoade
Distribuie
